Rezultaty - G. Lo Russo
- Rezultaty 1 - 2 Rezultaty od 2
-
1
57O Randomized double-blind phase II trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC: Primary results od Solange Peters, S.M. Lim, A.L. Ortega Granados, G.D.J. Pinto, C.S. Fuentes, G. Lo Russo, M. Schenker, J.S. Ahn, M. Reck, Z. Szijgyarto, N. Huseinovic, E. Zografos, S. O’Donnell, F. de Marinis
Wydane 2022Artigo -
2
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671) od Claudia Proto, M. Ganzinelli, Sara Manglaviti, Martina Imbimbo, Giulia Galli, Mirko Marabese, Fabiana Zollo, M.F. Alvisi, M. Perrino, Nadia Cordua, Federica Borea, Fabio De Vincenzo, A. Chella, Susanna Cappelli, E. Pardini, Z. Ballatore, A. Lucarelli, Elisa Ambrosini, Mariateresa Giuliano, Erica Pietroluongo, C. Mulargiu, Agnese Fabbri, Arsela Prelaj, Mario Occhipinti, M. Brambilla, L. Mazzeo, T. Beninato, R. Vigorito, Margherita Ruggirello, Francesca Gabriella Greco, G. Calareso, Daniela Miliziano, Eliana Rulli, Irene De Simone, Valter Torri, Filippo de Braud, G. Pasello, Pietro De Placido, Romeo S. Berardi, Iacopo Petrini, Paolo Andrea Zucali, Marina Chiara Garassino, G. Lo Russo
Wydane 2024Artigo